Are Scleral Lenses Covered by Insurance?

Learn the dual path to securing scleral lens coverage: establishing medical necessity and navigating vision vs. medical plans.

Scleral lenses are covered by insurance in some circumstances, but the answer depends almost entirely on why you need them, what type of insurance you carry, and whether your insurer agrees the lenses are medically necessary. When prescribed for a diagnosed corneal disease or ocular surface condition, many medical insurance plans will at least partially cover them. When they fall under a vision plan or are classified as refractive correction, coverage drops sharply or disappears. The gap between what these lenses cost and what patients actually get reimbursed remains a persistent problem, with research documenting annual out-of-pocket spending that can run into the thousands of dollars even for people who have insurance.

Why the Type of Insurance Matters More Than Whether You Have It

The single biggest factor in scleral lens coverage is not your insurer’s name on your card. It is whether the claim gets routed through medical insurance or vision insurance. These two systems treat scleral lenses very differently, and many patients discover this only after receiving a bill.

Vision insurance is designed around routine eye care: annual exams, standard eyeglasses, and off-the-shelf contact lenses. Most vision plans cap contact lens benefits at a few hundred dollars per year, which barely covers a fraction of scleral lens costs. Even when a vision plan technically includes contact lenses, it typically does not fully cover medically necessary treatments like scleral lenses prescribed for corneal disease. The additional cost of obtaining vision insurance can itself be a barrier for patients with limited means, and even when obtained, the coverage often falls short of what is needed for specialty lenses addressing conditions where ordinary glasses or soft contacts simply do not work.

Medical insurance, by contrast, can cover scleral lenses when they are prescribed as a therapeutic device for a specific medical diagnosis. The critical distinction is that the lenses must be deemed medically necessary rather than simply correcting refractive error. If your ophthalmologist or corneal specialist documents that you have a condition for which scleral lenses are the appropriate or only viable treatment, the claim can be submitted to your medical plan. This does not guarantee approval, but it opens the door in a way that vision insurance rarely does.

Diagnoses That Typically Qualify

Not every scleral lens prescription will be seen as medically necessary by an insurer. The conditions most commonly accepted as qualifying diagnoses include keratoconus, pellucid marginal degeneration, corneal ectasia after refractive surgery, post-transplant corneal irregularity, severe dry eye disease, Stevens-Johnson syndrome, and corneal scarring. What ties them together is that standard eyeglasses and conventional soft contact lenses cannot adequately correct the vision problems these conditions cause.

Keratoconus is by far the most common reason people end up in scleral lenses, and it is the condition around which much of the insurance coding and prior authorization language has been built. Corneal ectasia and highly irregular astigmatism from scarring are also well-recognized indications. Post-surgical rehabilitation, particularly after corneal transplants such as penetrating keratoplasty, is another well-documented pathway. In studies of patients fitted with mini-scleral lenses after corneal transplants, the main barriers to obtaining lenses were economic and handling concerns, underscoring that cost remains a hurdle even when the medical justification is clear.

Severe dry eye disease is a somewhat trickier category for coverage. While scleral lenses are increasingly recognized as effective for moderate to severe ocular surface disease, insurers vary widely in whether they classify dry eye as a qualifying condition for specialty lenses. If you have dry eye secondary to an autoimmune condition like Sjögren’s syndrome or graft-versus-host disease, the underlying systemic diagnosis may strengthen your case. If your dry eye is classified as routine or mild, expect more pushback.

The Medicaid Problem

Public insurance adds another layer of complexity. Medicaid coverage for scleral lenses varies by state, and the disparities are well documented. A study of keratoconus patients found that those on Medicaid were only about half as likely to receive rigid gas-permeable or scleral lenses compared to commercially insured patients, while being roughly twice as likely to undergo corneal cross-linking instead. That pattern suggests that access to scleral lenses tracks with insurance type, not just clinical need. If your insurer does not cover specialty lenses, the default treatment pathway shifts toward procedures that the insurance will pay for.

Some state Medicaid programs do include pathways for medically necessary contact lenses. California’s Medi-Cal, for example, has established coverage for medically necessary contact lenses limited to specific conditions like keratoconus and corneal pathology or deformity. But coverage remains inconsistent and often limited in scope across states. What qualifies in California may not qualify in Texas or Ohio, and even within a state, the prior authorization process and reimbursement rates can make it impractical for providers to accept Medicaid for these fittings.

The downstream effect is that patients with public insurance or no insurance are more likely to go without scleral lenses even when they would clinically benefit from them. Gaps in public insurance coverage for specialty ophthalmic services contribute to preventable vision loss among underserved populations, a problem that has spurred the creation of dedicated cost-coverage programs at some safety-net hospitals.

What Scleral Lenses Actually Cost

Even with medical insurance, scleral lenses are expensive. The fitting process alone involves multiple visits, often with a corneal specialist, and the lenses themselves are custom-manufactured for each eye. A pair of scleral lenses typically costs somewhere between $1,500 and $4,000 or more, depending on the design complexity and the number of fitting appointments required. Replacement lenses are needed periodically, and the specialty solutions used for insertion add ongoing costs.

Survey data from patients with dry eye disease paint a stark picture of what scleral lens wearers actually spend. Median annual expenditure for scleral lens wearers was around $1,500, substantially higher than the $500 median for patients managing dry eye without lenses or the $700 median for soft lens wearers. But the mean annual out-of-pocket cost for scleral lens wearers was even more striking: roughly $3,000, with wide variation. The estimated cost of the lenses and solutions alone was more than three times higher for scleral lens wearers compared to soft lens wearers.

That gap between the median and mean out-of-pocket figures (roughly $1,500 vs. $3,000) tells you something important: most scleral lens wearers pay a moderately high amount, but some are paying dramatically more, likely those with less generous insurance or with conditions requiring more frequent replacements and follow-up care. This is not a cost that neatly settles at one number for everyone.

How to Improve Your Chances of Getting Coverage

If you need scleral lenses and want your medical insurance to cover them, the process almost always involves prior authorization. Your provider submits documentation to the insurer explaining why scleral lenses are medically necessary for your specific condition. The strength of that documentation matters enormously.

A few practical steps can make a real difference:

  • Get the right provider: A corneal specialist or a contact lens fitter experienced with scleral lenses will know how to code the claim and what documentation insurers expect. A general optometrist prescribing scleral lenses for the first time may not navigate the authorization process as effectively.
  • Document failed alternatives: Insurers are more likely to approve scleral lenses when your records show that you tried and failed with glasses, soft contacts, or standard rigid gas-permeable lenses. If those options were never adequate for your condition, your provider should document why in the clinical notes before submitting the authorization.
  • Use medical diagnostic codes: The claim needs to be filed under a medical diagnosis code, not a refractive code. Keratoconus, corneal transplant, and corneal irregularity each have specific codes that signal medical necessity. If the claim is coded as simple myopia or astigmatism, it will almost certainly be denied.
  • Request a letter of medical necessity: Many insurers require or respond well to a detailed letter from your specialist explaining the diagnosis, why alternative treatments are inadequate, and why scleral lenses are the appropriate intervention. Ask your provider if they have a template or standard letter they use for these situations.

Even with all of this in place, initial denials are common. Insurers routinely deny prior authorizations for specialty contact lenses on the first pass, sometimes with generic language about the lenses being “not medically necessary” or “cosmetic.” If your claim is denied, you have the right to appeal, and the appeal is often where the real decision gets made. Many patients who are denied on the first try succeed on appeal when their provider submits additional documentation or a peer-to-peer review with the insurer’s medical director.

What Partial Coverage Looks Like in Practice

When insurance does cover scleral lenses, it rarely covers the full cost. More commonly, your plan will cover a portion of the fitting and the lenses themselves, leaving you responsible for a significant copay or coinsurance. Some plans cover the fitting visits as specialist office visits (subject to your specialist copay) but reimburse only a fixed amount toward the lenses, which may be several hundred dollars less than the actual cost. Others cover the lenses at a percentage, such as 80%, leaving you responsible for the remaining 20% of what can be a $2,000 to $4,000 bill.

Replacement lenses add another wrinkle. Many plans that cover the initial fitting and first set of lenses impose limits on how frequently they will pay for replacements. If your lenses need to be replaced annually but your plan only covers new lenses every two years, you are paying full price for every other set. Solutions and maintenance supplies are almost never covered by medical insurance and add a steady ongoing cost.

The result is that even patients with decent medical insurance and an approved prior authorization often end up paying $1,000 or more per year out of pocket for their scleral lenses. Patients with less generous plans, high deductibles, or public insurance can face much steeper costs. The survey data showing a mean annual out-of-pocket cost near $3,000 for scleral lens wearers reflects this reality across a mix of insurance types.

Safety-Net Programs and Alternative Funding

For patients who cannot afford scleral lenses even with insurance, a handful of programs exist to help bridge the gap. The most well-documented is the ACCESS (Alleviating Costs for Critical Eye Specialty Services) program at Zuckerberg San Francisco General Hospital, which delivers essential vision-restorative treatments, including scleral lenses, at no cost to qualifying patients through a combination of hospital support and philanthropic funding. Early outcomes from the program showed significant reductions in visual disability among patients who received treatment, along with economic benefits that outweighed program costs.

Programs like ACCESS remain the exception rather than the rule, however. Most patients without adequate coverage have to cobble together funding from multiple sources. Some options worth exploring include health savings accounts (HSAs) and flexible spending accounts (FSAs), which allow you to pay for scleral lenses with pre-tax dollars if your plan qualifies. Charitable organizations focused on eye health, such as the National Keratoconus Foundation and some local Lions Club chapters, occasionally provide financial assistance. Some scleral lens manufacturers offer patient assistance programs or payment plans, and some fitting practices offer in-house financing.

If you are on Medicaid and your state program does not cover scleral lenses, it is worth asking your provider whether your state has a specific exception process or whether a referral to an academic medical center with a specialty contact lens clinic might open different coverage pathways. Academic centers sometimes have access to research programs or institutional funds that private practices do not.

International Differences in Coverage

Coverage patterns outside the United States vary considerably. In countries with national health systems, scleral lenses for medically necessary conditions may be covered under the public system, though wait times and referral requirements can be significant. Research into the cost-benefit picture of specialty contact lenses for irregular corneas and ocular surface disease from the patient’s perspective is ongoing and spans multiple health systems. In some European and Commonwealth countries, the lenses may be fully funded for approved diagnoses but available only through hospital-based contact lens departments rather than private practitioners. In others, patients face out-of-pocket costs comparable to or exceeding those in the United States.

The common thread across health systems is that scleral lens coverage almost always requires a clear medical diagnosis and a documented failure of simpler alternatives. The gatekeeping mechanisms differ by country, but the underlying logic is the same: insurers and public health systems will pay for scleral lenses when there is evidence that nothing else will adequately restore functional vision for the patient’s condition. Patients everywhere face some version of the documentation and authorization hurdle, and economic barriers remain a real factor in who ultimately receives these lenses and who does not.